The latest news, developments and research findings from all fields of science including biology, chemistry, physics, psychology, sociology and space, including news on the latest policies regulating this sector.
The European Innovation Council (EIC) Fund has taken the following steps toward strengthening Europe's technological sovereignty by finalising its first two equity investments under the new EIC Step Scale Up scheme.
Jay Sibbitts, Shu Jia, Obdulia Covarrubias-Zambrano, Stefan H. Bossmann and Christopher T Culbertson from Kansas State University’s Department of Chemistry walk us through what we need to know about microfluidic devices for detecting pain.
Philippe JACQUES, Managing Director of EMIRI, explores how advanced materials can be used to solve global challenges such as the current COVID-19 pandemic.
Aarthi Janakiraman, Research Manager, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explores if nanotechnology aids the battle against COVID-19.
Researchers from The University of Manchester, Salford Royal and Res Consortium prove that over 25% of the UK are likely to have contracted COVID-19 already.
Here, Megan Warrender looks into the strides being made by the NIDCR to support dental research and innovation, and, in particular, how current initiatives feed into long term plans for dental, oral and craniofacial health and disease in the U.S.
Here, R.M Winglee and M. Danner, Department of Earth and Space Sciences, University of Washington, discuss robotic exploration and High-Velocity Impactors.
Studies suggest that the use of mesenchymal stem cells collected from umbilical cord blood and tissue are a safe and effective way to alleviate symptoms of coronavirus and promote fast recovery.
The Division of Chemistry at the National Science Foundation, provides an update on their work in driving discovery and development concerning chemistry research that improves the quality of life in the United States.
Mike Fischer CBE, Founder of the COVID-19 Volunteer Testing Network, details the work being done to keep healthcare workers safe on the frontline and provide regular screening for COVID-19.
Scientists at TCS designed novel chemical compounds using AI that can inhibit the 3CL protease of SARS-CoV-2, which is responsible for viral replication. Ananth Krishnan, Chief Technology Office, TCS, discusses the research here.
Several drugs used for curing hepatitis C have been identified as potential candidates to treat COVID-19, according to research conducted using the MOGON II supercomputer at Johannes Gutenberg University Mainz.
